Mizuho Securities USA LLC Has $1.74 Million Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Mizuho Securities USA LLC lifted its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 46.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,875 shares of the medical device company's stock after purchasing an additional 5,963 shares during the quarter. Mizuho Securities USA LLC's holdings in Cooper Companies were worth $1,735,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of COO. State Street Corp boosted its holdings in Cooper Companies by 1.2% during the third quarter. State Street Corp now owns 8,590,689 shares of the medical device company's stock valued at $947,897,000 after purchasing an additional 104,521 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of Cooper Companies by 13.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock worth $543,979,000 after buying an additional 573,908 shares during the period. Geode Capital Management LLC boosted its stake in Cooper Companies by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company's stock valued at $527,476,000 after buying an additional 48,559 shares in the last quarter. Victory Capital Management Inc. grew its position in Cooper Companies by 14.6% in the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock valued at $415,985,000 after acquiring an additional 574,899 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Cooper Companies by 11.9% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company's stock worth $200,665,000 after acquiring an additional 194,118 shares in the last quarter. 24.39% of the stock is owned by institutional investors.

Remove Ads

Wall Street Analyst Weigh In

A number of research firms have commented on COO. StockNews.com lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a research report on Wednesday, December 11th. Piper Sandler reiterated an "overweight" rating and issued a $115.00 target price (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. JPMorgan Chase & Co. decreased their price target on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Friday, March 7th. BNP Paribas upgraded Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Finally, Morgan Stanley decreased their target price on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a report on Friday, December 6th. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $110.25.

Cooper Companies Trading Down 1.4 %

Shares of COO traded down $1.21 during trading hours on Friday, reaching $83.77. The stock had a trading volume of 1,736,366 shares, compared to its average volume of 1,343,868. The company has a market cap of $16.75 billion, a P/E ratio of 42.96, a P/E/G ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a 52 week low of $77.05 and a 52 week high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The firm has a 50-day moving average of $89.33 and a 200 day moving average of $97.29.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting analysts' consensus estimates of $0.92. The company had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. On average, sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.